Prof. Dr. Jens Huober
chief physician
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer
Huober J, Meyer A, Wagner U, Wallwiener D. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. Journal of cancer research and clinical oncology 2002; 128:153-60.
Mar 1, 2002The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer
Mar 1, 2002Journal of cancer research and clinical oncology 2002; 128:153-60
Huober Jens, Meyer A, Wagner U, Wallwiener D
Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression
Volkmann M, Zentgraf H, Fiehn W, Wallwiener D, Bastert G, Hänsel S, Ludwig J, Hajjar Y, Frey M, Gaugel D, Sinn H, Huober J. Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression. Oncology 2002; 63:297-305.
Jan 1, 2002Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression
Jan 1, 2002Oncology 2002; 63:297-305
Volkmann Martin, Zentgraf Hanswalter, Fiehn Walter, Wallwiener Diethelm, Bastert Gunther, Hänsel Susanne, Ludwig Jochen, Hajjar Yaser, Frey Manfred, Gaugel Dirk, Sinn Hans-Peter, Huober Jens
Mammakarzinom in der Schwangerschaft
Huober J, Wallwiener D. Mammakarzinom in der Schwangerschaft. Geburtsh Frauenheilk 2002; 62:904-906.
Jan 1, 2002Mammakarzinom in der Schwangerschaft
Jan 1, 2002Geburtsh Frauenheilk 2002; 62:904-906
Huober Jens, Wallwiener D
Der Stellenwert von Aromastasehemmern der dritten Generation in der endokrinen Theraphie des Mammakarzinoms - Zeit zum Umdenken
Huober J, Wagner U, Wallwiener D. Der Stellenwert von Aromastasehemmern der dritten Generation in der endokrinen Theraphie des Mammakarzinoms - Zeit zum Umdenken. Geburtsh Frauenheilk 2002; 62:15-21.
Jan 1, 2002Der Stellenwert von Aromastasehemmern der dritten Generation in der endokrinen Theraphie des Mammakarzinoms - Zeit zum Umdenken
Jan 1, 2002Geburtsh Frauenheilk 2002; 62:15-21
Huober Jens, Wagner U, Wallwiener D
Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001
Wagner U, Krebs D, Bauknecht T, Kreienberg R, Möbus V, Biersack H, Schlebusch H, Renke K, Huober J, Giffels P, Reinartz S, Köhler S, Wallwiener D. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001. Clinical cancer research : an official journal of the American Association for Cancer Research 2001; 7:1154-62.
May 1, 2001Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001
May 1, 2001Clinical cancer research : an official journal of the American Association for Cancer Research 2001; 7:1154-62
Wagner U, Krebs D, Bauknecht T, Kreienberg R, Möbus V, Biersack H J, Schlebusch H, Renke K, Huober Jens, Giffels P, Reinartz S, Köhler S, Wallwiener D
Primäre Chemotheraphie und Intervalllaparotomie beim fortgeschrittenen Ovarialkarzinom
Huober J, Meyer A, Wagner U, Wallwiener D. Primäre Chemotheraphie und Intervalllaparotomie beim fortgeschrittenen Ovarialkarzinom. Med. Welt 2001; 52:101-105.
Jan 1, 2001Primäre Chemotheraphie und Intervalllaparotomie beim fortgeschrittenen Ovarialkarzinom
Jan 1, 2001Med. Welt 2001; 52:101-105
Huober Jens, Meyer A, Wagner U, Wallwiener D
Qualitätssicherung in der operativen Theraphie von Ovarialtumoren
Huober J, Meyer A, Wagner U, Wallwiener D. Qualitätssicherung in der operativen Theraphie von Ovarialtumoren. Med. Welt 2001; 52:184-187.
Jan 1, 2001Qualitätssicherung in der operativen Theraphie von Ovarialtumoren
Jan 1, 2001Med. Welt 2001; 52:184-187
Huober Jens, Meyer A, Wagner U, Wallwiener D
Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer
Huober J, Nakamura S, Meyn R, Roth J, Mukhopadhyay T. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer. International journal of radiation oncology, biology, physics 2000; 48:1127-37.
Nov 1, 2000Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer
Nov 1, 2000International journal of radiation oncology, biology, physics 2000; 48:1127-37
Huober Jens, Nakamura S, Meyn R, Roth J A, Mukhopadhyay T
Die neoadjuvante endokrine Theraphie des Mammakarzinoms
Meyer A, Huober J, Krainick-Strobel U, Greb R, Wagner U, Wallwiener D. Die neoadjuvante endokrine Theraphie des Mammakarzinoms. Onkologe 2000; 1:67-71.
Jan 1, 2000Die neoadjuvante endokrine Theraphie des Mammakarzinoms
Jan 1, 2000Onkologe 2000; 1:67-71
Meyer A, Huober Jens, Krainick-Strobel U, Greb R, Wagner U, Wallwiener D
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Hohaus S, Wallwiener D, Martin S, Voso M, Huober J, Fersis N, Bastert G, Haas R. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Seminars in oncology 1998; 25:7-11; discussion 45-8.
Apr 1, 1998Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Apr 1, 1998Seminars in oncology 1998; 25:7-11; discussion 45-8
Hohaus S, Wallwiener D, Martin S, Voso M T, Huober Jens, Fersis N, Bastert G, Haas R
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Huober J, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D. Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer. Journal of cancer research and clinical oncology 1998; 124:690-4.
Jan 1, 1998Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Jan 1, 1998Journal of cancer research and clinical oncology 1998; 124:690-4
Huober Jens, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D
[Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]
Holz F, Bellmann C, Steffen H, Nölle B, Huober J, Krastel H, Alexandridis E. [Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997; 94:337-42.
May 1, 1997[Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]
May 1, 1997Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997; 94:337-42
Holz F G, Bellmann C, Steffen H, Nölle B, Huober Jens, Krastel H, Alexandridis E
[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
Huober J, Holz F, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G. [Paraneoplastic retinopathy in 2 patients with breast carcinoma]. Zentralblatt für Gynäkologie 1997; 119:278-81.
Jan 1, 1997[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
Jan 1, 1997Zentralblatt für Gynäkologie 1997; 119:278-81
Huober Jens, Holz F G, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G
Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
Hamann U, Costa S, Goette K, Huober J, Solomayer E, Kaufmann M, Bastert G, Komitowski D. Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. The Breast 1997; 6:5.
Jan 1, 1997Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
Jan 1, 1997The Breast 1997; 6:5
Hamann U, Costa SD, Goette K, Huober Jens, Solomayer EF, Kaufmann M, Bastert G, Komitowski D
Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
Huober J, Grischke E, Hahn U, Wallwiener D, Bastert G. Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta. Gynäkolo. prax 1997; 21:685-689.
Jan 1, 1997Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
Jan 1, 1997Gynäkolo. prax 1997; 21:685-689
Huober Jens, Grischke E-M, Hahn U, Wallwiener D, Bastert G
[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. Geburtshilfe und Frauenheilkunde 1996; 56:214-6.
Apr 1, 1996[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Apr 1, 1996Geburtshilfe und Frauenheilkunde 1996; 56:214-6
Huober Jens, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G
[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
Huober J, Sprenger H, Costa S, Zentgraf H, Schmid H, Kaufmann M, Bastert G. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]. Zentralblatt für Gynäkologie 1996; 118:560-4.
Jan 1, 1996[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
Jan 1, 1996Zentralblatt für Gynäkologie 1996; 118:560-4
Huober Jens, Sprenger H, Costa S D, Zentgraf H, Schmid H, Kaufmann M, Bastert G
[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
Mende U, Huober J, Schmid H, Winterbauer T, Bastert G, Wannenmacher M. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]. Der Radiologe 1996; 36:22-30.
Jan 1, 1996[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
Jan 1, 1996Der Radiologe 1996; 36:22-30
Mende U, Huober Jens, Schmid H, Winterbauer T, Bastert G, Wannenmacher M
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Sinn H, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto H. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe und Frauenheilkunde 1994; 54:552-8.
Oct 1, 1994[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Oct 1, 1994Geburtshilfe und Frauenheilkunde 1994; 54:552-8
Sinn H P, Schmid H, Junkermann H, Huober Jens, Leppien G, Kaufmann M, Bastert G, Otto H F
Klinisch relevante Prognosefaktoren beim Mammakarzinom
Costa S, von Minkwitz G, Gremm B, Huober J, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel I, Kaufmann M, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
Jan 1, 1994Klinisch relevante Prognosefaktoren beim Mammakarzinom
Jan 1, 1994Klin Lab 1994; 40:1153-1166
Costa SD, von Minkwitz G, Gremm B, Huober Jens, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel IJ, Kaufmann M, Bastert G